In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Life Technologies Inc.

Division of Takeda Pharmaceutical Co. Ltd./Shire PLC/Baxalta Inc./Synovis Life Technologies Inc./Micro Companies Alliance
www.lifetech.com

Latest From Life Technologies Inc.

Biosimilar Litigation: Celltrion, Pfizer Claim Victory On Janssen’s Remaining Infringement Claim

Ensnarement defense bars Remicade maker from prevailing on claim that Inflectra partners infringed cell culture media patent, US federal judge rules.


Biosimilars Intellectual Property

Biosimilar Litigation: Celltrion, Pfizer Claim Victory On Janssen’s Remaining Infringement Claim

Ensnarement defense bars Remicade maker from prevailing on claim that Inflectra partners infringed cell culture media patent, US federal judge rules.


Biosimilars Intellectual Property

Legal News In Brief

Enzo and Illumina settle patent battle; Bard and Gore argue over jury logistics for an upcoming trial; and former employee alleges False Claims Act violations by medical equipment maker Lincare.

Legal Issues Legal Issues

Quest Wins First Commercial Zika Test FDA Emergency-Use Approval

FDA approved the first emergency-use authorization for a commercially developed, molecular-based Zika virus diagnostics, developed by Quest's Focus Diagnostics subsidiary.

Medical Device Regulation
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register